91 filings
Page 2 of 5
8-K
xpkwwzg5
6 Apr 20
Regulation FD Disclosure
2:21pm
8-K
u952hb vmxwc
1 Apr 20
Innovation Pharmaceuticals Receives Data Supporting Brilacidin’s Direct Inhibition of SARS-CoV-2, the Novel Coronavirus Responsible for COVID-19
12:00pm
8-K
kf35rhgt3fp89f4
6 Mar 20
Innovation Pharmaceuticals Signs Second MTA to Explore Brilacidin as Coronavirus
12:00pm
8-K
cij 0d5n2hixp
27 Feb 20
Regulation FD Disclosure
12:00pm
8-K
fm2qc6ifie6add
13 Feb 20
Innovation Pharmaceuticals Phase 1 Trial of Brilacidin for Ulcerative Colitis Meets Primary Endpoints; Positive Topline Results of Oral Brilacidin
4:05pm
8-K
0fxszy qd5
26 Dec 19
Entry into a Material Definitive Agreement
5:16pm
8-K
l69wiu 5b
24 Dec 19
Departure of Directors or Certain Officers
12:00am
8-K
xjy 3oovio
20 Sep 19
Amendments to Articles of Incorporation or Bylaws
4:33pm
8-K
maiv4
22 Jul 19
Entry into a Material Definitive Agreement
9:30am
8-K
cxp4q6d2ggixme q5dg
16 May 19
Regulation FD Disclosure
10:15am
8-K
57rte6u s1
10 May 19
Entry into a Material Definitive Agreement
7:32am
8-K
t6og74qoug43
31 Jan 19
Regulation FD Disclosure
4:15pm
8-K
w771aw
7 Jan 19
Departure of Directors or Certain Officers
4:30pm
8-K
sqbzxy
18 Dec 18
Changes in Registrant's Certifying Accountant
5:00pm
8-K
txuj1og9kmoj0g0rn
17 Dec 18
Regulation FD Disclosure
7:05am
8-K
kgfe x8oe9i
17 Dec 18
Departure of Directors or Certain Officers
7:00am
8-K
9wm04 9ddupb
13 Nov 18
Other Events
7:15am
8-K
z0u84t
24 Oct 18
Regulation FD Disclosure
7:00am
8-K
34xbztbvxxt
10 Oct 18
Regulation FD Disclosure
10:55am
8-K
twqpn9kf
9 Oct 18
Innovation Pharmaceuticals Secures Up to $10 Million in Additional Financing to Advance Clinical Pipeline
6:52am